CClinicalTrials.gg
Not yet recruitingNCT06038266Updated Sep 14, 2023

Predictors of Hospital Readmission for Patients Undergoing Cardiac Surgeries

An observational study in Cardiac Surgery, Readmission, sponsored by Assiut University. Not yet recruiting. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2023-09-14.

Sponsored by Assiut University · Observational

From the registry’s dates

  • Primary completion was expected by Mar 2024, 2 years 7 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
121
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This study aimed to identify the predictors of hospital readmission for patients undergoing cardiac surgeries.

Read the detailed description

Cardiovascular diseases (CVDs) are conditions of the heart and blood vessels that lead to significant morbidity and mortality, burden the global public health system, and are the main cause of death worldwide. CVD accounted for approximately 19.05 million global deaths in 2020. CVD is listed as the first underlying cause of death, with more than 800000 deaths in the United States in 2019. Between 2015 and 2018, 126.9 million US adults had some form of CVD. Between 2017 and 2018, direct and indirect costs of total CVD were $378.0 billion ($226.2. billion in direct costs and $151.8 billion in lost productivity/mortality).

Cardiac surgery continues to play an important role in the management of various cardiovascular disorders, including the treatment of seriously and critically ill patients. The most frequently performed procedures include coronary artery bypass graft (CABG) and valvular surgery. According to the Society of Thoracic Surgeons, the number of cardiac surgeries exceeds 300000 procedures in 2019 in the United States. Despite tremendous advancements in cardiac surgery over the past few years, postoperative hospital readmissions after cardiac surgeries still present significant challenges.

Readmission occurs when a patient is admitted to the same or a different hospital after being discharged from the relevant hospital and placed in a non-acute setting, such as his home, within a predetermined amount of time. Readmission within 30 days of adult cardiac surgery is a difficult and costly problem, with rates ranging from 8% to 21%. In addition to delayed return to activities of daily living and reduced quality of life, readmission is associated with a financial cost for patients and healthcare facilities. Increased facility costs can be substantial, especially when combined with reimbursement penalties, the cost of skilled care, and potential legal expenses.

Readmission after cardiac surgery is common and moderately predictable. According to a study done in a multi-institutional hospital in Ontario, Canada on patients who underwent CABG and/or valve surgery from 2008 to 2016, the 30-day readmission rate was 11.5% overall. Patients who were readmitted were older with higher incidences of cardiac comorbidities compared with non-readmitted patients. Significant risk factors for readmission from the final model were the prolonged length of stay, isolated valve surgery, in-hospital complications of sepsis, acute myocardial infarction, diabetes mellitus, gastrointestinal problems wound infection, postoperative acute renal failure, atrial fibrillation (AF), chronic lung disease, obesity, hematocrit \<35% before surgery, cardiopulmonary bypass, especially bypass durations of more than 100 minutes.

Perioperative nurses may positively affect reducing readmission rates at different stages of the perioperative continuum of care. All nursing interventions play an important role in minimizing patient risk and preventing or reducing the number of readmissions. Nursing strategies to reduce postoperative cardiac surgery readmission include central line and urinary catheter insertion, cardiopulmonary bypass circuit maintenance, temperature regulation, hair removal, and skin preparation, glycemic control, care of the incision site, treatment and prevention of dysrhythmia, pleural effusion and retained blood syndrome, appropriate discharge teaching, following up with the patients after discharge through telephone conversations and post-discharge care.

Reducing readmission after cardiac surgery remains a quality improvement priority. most readmission risk models examine only coronary artery bypass grafting (CABG). So, this study will be carried out to identify predictors of patients' postoperative readmission after cardiac surgery, including CABG \& valvular surgeries.

02

Conditions studied

  • Cardiac Surgery, Readmission
03

In context

Lead sponsor

Assiut University is the lead sponsor of 4,901 studies on the registry; 2,098 are open to participants now.

Of its 13 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

The study will include a sample of 121 adult patients (male and female) who are undergoing CABG or Cardiac Valvular surgeries and whose age is from 18 to 65 years old.

Inclusion criteria

  • The study will include a sample of 121 adult patients (male and female) who are undergoing CABG or Cardiac Valvular surgeries and whose age is from 18 to 65 years old.

Exclusion criteria

Exclusion Criteria:

  • Failed surgery
  • Psychiatric patient
  • Patient refusal to participate in the study
  • Aortic surgeries
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
121 participants (estimated)
Patient registry
No

Interventions

  • Procedurecardiac surgeries

    predict perioperative risk factors for readmission after cardiac surgeries

06

What researchers measure

Primary outcomes

  1. detect perioperative risk factors for hospital readmission in patients whose undergoing cardiac surgeries

    analysis of pre, intra and postoperative risk factors that may cause readmission for patients undergoing Valvular surgery or Coronary artery bypass grafting (CABG)

    Time frame: baseline

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Iribarne A, Chang H, Alexander JH, Gillinov AM, Moquete E, Puskas JD, Bagiella E, Acker MA, Mayer ML, Ferguson TB, Burks S, Perrault LP, Welsh S, Johnston KC, Murphy M, DeRose JJ, Neill A, Dobrev E, Baio KT, Taddei-Peters W, Moskowitz AJ, O'Gara PT. Readmissions after cardiac surgery: experience of the National Institutes of Health/Canadian Institutes of Health research cardiothoracic surgical trials network. Ann Thorac Surg. 2014 Oct;98(4):1274-80. doi: 10.1016/j.athoracsur.2014.06.059. Epub 2014 Aug 28. PubMed 25173721 ↗
  • Seifert PC. Reducing Readmissions After Coronary Artery Bypass Grafting. AORN J. 2017 Oct;106(4):332-337. doi: 10.1016/j.aorn.2017.08.009. No abstract available. PubMed 28958319 ↗
  • Ferraris VA, Ferraris SP, Harmon RC, Evans BD. Risk factors for early hospital readmission after cardiac operations. J Thorac Cardiovasc Surg. 2001 Aug;122(2):278-86. doi: 10.1067/mtc.2001.114776. PubMed 11479500 ↗
  • Demissie, D. B., Doge, G., & Werba, T. B. (2023). The Magnitude of 30-Day Readmission and Factors Associated with Patients Underwent Cardiac Surgery in Tikur Anbessa Specialized Hospital Cardiac Center, Ethiopia. Research Reports in Clinical Cardiology, Volume 14, 35-48. https://doi.org/10.2147/rrcc.s407183
  • Stephens RS, Whitman GJ. Postoperative Critical Care of the Adult Cardiac Surgical Patient. Part I: Routine Postoperative Care. Crit Care Med. 2015 Jul;43(7):1477-97. doi: 10.1097/CCM.0000000000001059. PubMed 25962078 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 14, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06038266
Lead sponsor
Assiut University
Responsible party
Mahmoud Fathy Abdelhafeez Soliman (Mr., Assiut University) — Principal investigator
First posted
Sep 14, 2023
Start date
Sep 2023 (estimated)
Primary completion
Mar 2024 (estimated)
Completion
Apr 2024 (estimated)
Last update
Sep 14, 2023

Study contacts

Mahmoud FathI Abdelhafeez Soliman, BSN
Contact
mahmoud808@aun.edu.eg
+201006579808
Marwa Ali Almasry, Ass.Prof
study director · Assistant professor of medical surgical nursing

Oversight

Data monitoring committee
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion